Effects of aquaporin4 deficiency on opioid receptors characteristics in naive and chronic morphine-treated mice

Neuroscience Letters

Volumn 457, Issue 3, 2009, Pages 111-114

  Wang, Ji Fang ^a   Wang, Zhi Yuan ^b   Wu, Ning ^a   Yan, Hai Tao ^a   Li, Jin ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Affinity; Aquaporin4; Density; Morphine; Opioid receptors

Indexed keywords

AQUAPORIN 4; DIPRENORPHINE; MORPHINE; OPIATE RECEPTOR;

ARTICLE; BRAIN REGION; DRUG EXPOSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECEPTOR AFFINITY; RECEPTOR DENSITY; WESTERN BLOTTING;

ANALGESICS, OPIOID; ANIMALS; AQUAPORIN 4; BRAIN; CELL MEMBRANE; DIPRENORPHINE; MICE; MICE, KNOCKOUT; MORPHINE; RADIOLIGAND ASSAY; RECEPTORS, OPIOID; TRITIUM;

EID: 67349248107     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.03.060     Document Type: Article

References (26)

1. Badaut J., Brunet J.F., and Regli L. Aquaporins in the brain: from aqueduct to "multi-duct. Metab. Brain Dis. 22 (2007) 251-263
2. Bergasa N.V., Rothman R.B., Mukerjee E., Vergalla J., and Jones E.A. Up-regulation of central μ-opioid receptor in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure. Life Sci. 70 (2002) 1701-1708
3. Bergasa N.V., Rothman R.B., Vergalla J., Xu H., Swain M.G., and Jones E.A. Central μ-opioid receptors are down-regulated in a rat model of cholestasis. J. Hepatol. 15 (1992) 220-224
4. Binder D.K., Yao X., Zador Z., Sick T.J., Verkman A.S., and Manley G.T. Increased seizure duration and slowed potassium kinetics in mice lacking Aquaporin-4 water channels. Glia 53 (2006) 631-636
5. Brady L.S., Herkenham M., Long J.B., and Rothman R.B. Chronic morphine increases μ-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 477 (1989) 382-386
6. Clarke S., Zimmer A., Zimmer A.M., HillR G., and Kitchen I. Region selective up-regulation of μ-, δ- and κ-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice. Neuroscience 122 (2003) 479-489
7. Fabian G., Bozo B., Zikszay S.M., Horvath G., Oscia C.C.J., and Szucs M. Chronic morphine-induced changes in μ-opioid receptors and G proteins of different subcellular loci in rat brain. J. Pharmacol. Exp. Ther. 302 (2002) 774-780
8. Gerrits M.A.F.M., Lesscher H.B.M., and van Ree J.M. Opioid dependence and the endogenous opioid system. Eur. Neuropsychopharm. 13 (2003) 424-434
9. Hasegawa H., Ma T., Skach W., Matthay M., and Verkman A.S. Molecular cloning of a mercurial-insensitive water channel expressed in selected water transporting tissues. J. Biol. Chem. 269 (1994) 5497-5500
10. Heidbreder C.A., and Hagan J.J. Novel pharmacotherapeutic approaches for the treatment of opioid addiction and craving. Curr. Opin. Pharmacol. 5 (2005) 107-118
11. Li Z., Gao L., Liu Q., Cao C., Sun X.L., Ding J.H., and Hu G. Aquaporin-4 KO regulated cocaine-induced behavior and neurochemical changes in mice. Neurosci. Lett. 403 (2006) 294-298
12. Ma T., Yang B., Gillespie A., Carlson E.J., Epstein C.J., and Verkman A.S. Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin 4. J. Clin. Invest. 100 (1997) 957-962
13. Matthes H.W.D., Maldonado R., and Simonin F. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature 383 (1996) 819-823
14. Meuser T., Giesecke T., Gabriel A., Horsch M., Sabatowski R., Hescheler J., Grond S., and Palmer P.P. μ-opioid receptor mRNA regulation during morphine tolerance in the rat peripheral nervous system. Anesth. Anal. 97 (2003) 1458-1463
15. + siphoning and water transport in rat retinal Muller cells is mediated by a coenrichment of Kir4.1 and Aquaporin-4 in specific membrane domains. Glia 26 (1999) 47-54
16. Nagelhus E.A., Mathiisen T.M., and Ottersen O.P. Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 129 (2004) 905-913
17. Onoprishvili I., and Simon E.J. Chronic morphine treatment up-regulates μ-opioid receptor binding in cells lacking filamin A. Brain Res. 1177 (2007) 9-18
18. +-sensing fluorescent indicator. Nat. Methods 2 (2005) 825-827
19. Pawar M., Kumar P., Sunkaraneni S., Sirohi S., Walker E.A., and Yoburn B.C. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of μ-opioid receptor and dynamin-2. Eur. J. Pharmacol. 563 (2007) 92-101
20. Ruff C.G., Matthes H.W.D., and Peluso J. Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor gene. Proc. Natl. Acad. Sci. 95 (1998) 6236-6330
21. Stafford K., Gomes A.B., Shen J., and Yoburn B.C. μ-Opioid receptor down-regulation contributes to opioid tolerance in vivo. Pharmacol. Biochem. Behav. 69 (2001) 233-237
22. Verbavatz J.M., Ma T., Gobin R., and Verkman A.S. Absence of orthogonal arrays in kidney, brain and muscle from transgenic knockout mice lacking water channel Aquaporin-4. J. Cell Sci. 110 (1997) 2855-2860
23. Viganò D., Rubino T., Chiara G., Ascari I., Massi P., and Parolaro D. μ-opioid receptor signaling in morphine sensitization. Neuroscience 117 (2003) 921-929
24. Wu N., Lu X.Q., Yan H.T., Su R.B., Wang J.F., Liu Y., Hu G., and Li J. Aquaporin-4 deficiency modulates morphine pharmacological actions. Neurosci. Lett. 448 (2008) 221-225
25. Yoko H., Tani K., Akiko K., Nobuhiko G., Kouki N., Hiroshi S., Thomas W., Sei S., Kaoru M., Kazushi K., Akira M., and Yoshinori F. Implications of the Aquaporin-4 structure on array formation and cell adhesion. J. Mol. Biol. 355 (2006) 628-639
26. Zhang Q.Y., Purohit V., and Yoburn B. Continuous opioid agonist treatment dose-dependently regulates μ-opioid receptors and dynamin-2 in mouse spinal cord. Synapse 56 (2005) 123-128